SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Diaz-Gutierrez MJ, Cengotitabengoa MM, Bermúdez-Ampudia C, García S, López P, Martínez-Cengotitabengoa M, Gonzalez-Pinto A. Exp. Gerontol. 2018; 110: 42-45.

Affiliation

Biomedical Research Centre in Mental Health Network (CIBERSAM) G10, Spain, University of the Basque Country, Spain; Psychiatry Department, BioAraba, Health Research Institute, Araba University Hospital, 29 Olaguibel Street, 01004 Vitoria, Spain.

Copyright

(Copyright © 2018, Elsevier Publishing)

DOI

10.1016/j.exger.2018.05.002

PMID

29751092

Abstract

INTRODUCTION: Benzodiazepines and Z drugs (BZD/Z drugs) are commonly used for the treatment of insomnia and anxiety in older adults for long periods of time. Given the physiological and metabolic characteristics of this group of patients, they are more prone to the adverse effects of these drugs which include falls. The recommendations for use of BZD/Z drugs include the need to adjust the dose and select those with a short half-life, to avoid adverse events, which as well as potentially affecting patient outcome, increase healthcare costs. In this study, we have evaluated the hospital-related costs associated with falls in older adults who use BZD/Z drugs at doses higher than recommended for this age group.

METHODS: We conducted a cross-sectional observational study assessing the BZD/Z drug prescriptions of older adults attending the emergency department after a fall. Cost analysis was performed for cases in which the prescriptions exceeded the maximum recommended dose for this age group.

RESULTS: A total of 40.6% of the prescriptions recorded were higher than the defined daily dose in older adults (DDDolderadults). Of the 57 patients who used BZD/Z drugs at higher-than-recommended doses, 53 experienced trauma and 33 required hospitalisation. The costs associated with emergency department services, tests performed and hospitalisation amounted to €1850/patient.

CONCLUSIONS: Appropriate dosage of BZD/Z drugs in older adults could reduce both patient suffering and costs for the health system.

Copyright © 2017. Published by Elsevier Inc.


Language: en

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print